Vytrus Biotech S.A. (VYT) — Cash Flow Reinvestment Rate
Vytrus Biotech S.A. (VYT) has a Cash Flow Reinvestment Rate of 2.19x as of December 2022, reinvesting €494.16K (capex €494.16K ) from operating cash flow of €225.55K. Check earnings quality score of Vytrus Biotech S.A. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vytrus Biotech S.A. Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Vytrus Biotech S.A. across 5 annual periods. Explore Vytrus Biotech S.A. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Vytrus Biotech S.A. (2021–2025)
Year-by-year capital reinvestment analysis for Vytrus Biotech S.A.. For live market cap and broader valuation context, see VYT market cap.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | €2.76 Million | €3.90 Million | €2.68 Million | ▲ +8.1% |
| 2024 | 0.65x | €1.21 Million | €1.84 Million | €1.20 Million | ▼ -49.9% |
| 2023 | 1.31x | €1.18 Million | €904.39K | €1.17 Million | ▼ -44.0% |
| 2022 | 2.33x | €526.44K | €225.55K | €494.16K | ▲ +245.3% |
| 2021 | 0.68x | €302.78K | €447.92K | €271.82K | — |